Merck

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Merck 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRK

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. 

CEO
Robert M. Davis
CEORobert M. Davis
Employees
75,000
Employees75,000
Headquarters
Rahway, New Jersey
HeadquartersRahway, New Jersey
Founded
1891
Founded1891
Employees
75,000
Employees75,000

MRK Key Statistics

Market cap
329.62B
Market cap329.62B
Price-Earnings ratio
135.63
Price-Earnings ratio135.63
Dividend yield
2.56%
Dividend yield2.56%
Average volume
8.69M
Average volume8.69M
High today
$137.17
High today$137.17
Low today
$132.37
Low today$132.37
Open price
$134.02
Open price$134.02
Volume
15.61M
Volume15.61M
52 Week high
$156.92
52 Week high$156.92
52 Week low
$93.90
52 Week low$93.90

Stock Snapshot

With a market cap of 329.62B, Merck(MRK) trades at $133.43. The stock has a price-to-earnings ratio of 135.63 and currently yields dividends of 2.56%.

As of 2026-11-20, Merck(MRK) stock has fluctuated between $132.37 and $137.17. The current price stands at $133.43, placing the stock +0.8% above today's low and -2.7% off the high.

The Merck(MRK)'s current trading volume is 15.61M, compared to an average daily volume of 8.69M.

During the past year, Merck(MRK) stock moved between $93.90 at its lowest and $156.92 at its peak.

During the past year, Merck(MRK) stock moved between $93.90 at its lowest and $156.92 at its peak.

MRK News

Benzinga 11h
Why Is Merck Stock Trading Higher Today? - Merck & Co - Benzinga

...

Why Is Merck Stock Trading Higher Today? - Merck & Co - Benzinga
Benzinga 11h
Merck Reports Positive Survival Data For Investigational Therapy for Advanced Gastric Cancer

Merck & Co. Inc. (NYSE:MRK) on Friday announced that its pivotal Phase 3 TroFuse-015 trial met its primary endpoint of overall survival (OS). Evaluating sacitu...

Merck Reports Positive Survival Data For Investigational Therapy for Advanced Gastric Cancer
Simply Wall St 12h
How Much Merck Do You Really Get Through 3 ETFs?

Owning Merck directly means you carry company specific issues by yourself, such as a dividend that Simply Wall St says is not well covered by earnings, or profi...

How Much Merck Do You Really Get Through 3 ETFs?

Analyst ratings

65%

of 31 ratings
Buy
64.5%
Hold
35.5%
Sell
0%

More MRK News

Seeking Alpha 14h
Dividend Roundup: Nvidia, Disney, Merck, Johnson & Johnson and more

This week's dividend activity included increased payouts from Merck (MRK) and Walt Disney (DIS) as well as declarations from Nvidia (NVDA) and Nike (NKE). Addi...

Dividend Roundup: Nvidia, Disney, Merck, Johnson & Johnson and more
TipRanks 16h
Merck says 3 TroFuse-015 trial of sacituzumab tirumotecan met primary endpoint

Merck (MRK) announced the pivotal Phase 3 TroFuse-015 trial evaluating sacituzumab tirumotecan, an investigational TROP2-directed antibody-drug conjugate licens...

Simply Wall St 1d
Merck Pairs AI Drug Discovery Deal With Nemtabrutinib Phase 3 Exit

Merck (NYSE:MRK) announced a new AI-focused drug discovery collaboration with Alphabet unit Isomorphic Labs centered on oncology research. The company said it...

Merck Pairs AI Drug Discovery Deal With Nemtabrutinib Phase 3 Exit
TipRanks 2d
Halozyme provides update on German preliminary injunction hearing

Halozyme (HALO) provided an update on the German preliminary injunction hearing that overturned the decision issued in December 2025, ordering Merck (MRK) to re...

Seeking Alpha 2d
Merck inks cancer research deal with AI drug discovery firm Isomorphic Labs

Merck (MRK) is joining hands with AI-driven drug discovery firm Isomorphic Labs to discover drug candidates against cancer, the companies announced on Thursday....

Merck inks cancer research deal with AI drug discovery firm Isomorphic Labs
TipRanks 2d
Merck and Isomorphic Labs to collaborate in drug discovery

Merck (MRK) and Isomorphic Labs, an AI-first drug design and development company, announced a research collaboration that brings together Isomorphic Labs’ AI ap...

TipRanks 2d
Merck Appoints Douglas Baker Jr. as Lead Director

Merck & Company ( (MRK) ) has provided an announcement. On Nov. 16, 2026, Thomas H. Glocer notified Merck of his intention to retire from its board at the May...

People also own

Based on the portfolios of people who own MRK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.